Updates are available Correction dated 2022-06-13
Click to view Correction: https://doi.org/10.1186/s12943-022-01593-x
-
Authors
Jin, Dan
Guo, Jiwei http://orcid.org/0000-0003-1636-6499
Wu, Yan
Yang, Lijuan
Wang, Xiaohong
Du, Jing
Dai, Juanjuan
Chen, Weiwei
Gong, Kaikai
Miao, Shuang
Li, Xuelin
Sun, Hongliang
-
Funding
Funding for this research was provided by:
National Aerospace Science Foundation of China (31801085)
Natural Science Foundation of Shandong Province (ZR2018QH004)
Key Technology Research and Development Program of Shandong (2019GSF108174)
- License Information
-
More Information
Article History
Received: 12 November 2019
Accepted: 13 February 2020
First Online: 27 February 2020
Change Date: 13 June 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12943-022-01593-x
Ethics approval and consent to participate
: The experimental protocol was approved by the Research Ethics Committee of Binzhou Medical University, China (No. 2018–016-08 for human lung cancer specimen and No. 2018–019-04 for mouse experiments in vivo) and the written informed consent was obtained from all subjects. Informed consent was obtained from all individual participants included in the study. All patients were staged based on the criteria of the 7th Edition of the AJCC Cancer Staging Manual (2010).
: The authors confirm that they have obtained written consent from each patient to publish the manuscript.
: The authors have declared that no competing interest exists.
